Результаты поиска - Restelli U

Financial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectives по Croce D, Bonfanti M, Restelli U

Полный текст

Co-Design as Enabling Factor for Patient-Centred Healthcare: A Bibliometric Literature Review по Silvola S, Restelli U, Bonfanti M, Croce D

Полный текст

Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem... по Restelli U, Croce D, Pacelli V, Ciceri F, Girmenia C

Полный текст

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy start... по Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D

Полный текст

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy start... по Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D

Полный текст

Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies... по Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D

Полный текст

Protocol Implementation for Normothermia in Surgery Settings in Italy: Budget-Impact Analysis по Monzani R, Barbera G, Restelli U, Galeone C, Petrini F

Полный текст

Health Technology Assessment for Fast-Track Elective Knee and Hip Arthroplasty in a High-Volume Orthopaedic Hospital in Italy по Restelli U, Vitale J, Croce E, Bernareggi S, Guida S, Silvola S, Banfi G, Zagra L

Полный текст

Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatm... по Restelli U, Rizzardini G, Antinori A, Lazzarin A, Bonfanti M, Bonfanti P, Croce D

Полный текст

Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study [Corrigendum] по Restelli U, Ceresoli GL, Croce D, Evangelista L, Maffioli LS, Gianoncelli L, Bombardieri E

Полный текст

Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study по Restelli U, Ceresoli GL, Croce D, Evangelista L, Maffioli LS, Gianoncelli L, Bombardieri E

Полный текст

Cost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile? по Rizzardini G, Restelli U, Bonfanti P, Porazzi E, Ricci E, Foglia E, Carenzi L, Croce D

Полный текст

Monocentric Analysis of the Effectiveness and Financial Consequences of the Use of Lenograstim versus Filgrastim for Mobilization of Peripheral Blood Progenitor Cells in Patients w... по Restelli U, Croce D, Bonizzoni E, Marzanatti M, Andreini A, Sorio M, Tecchio C, Barison E, Benedetti F

Полный текст

Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service по Restelli U, Andreoni M, Antinori A, Bonfanti M, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Croce D

Полный текст

The Economic Impact of Loss to Follow-Up in Eosinophilic Esophagitis: A Model-Based Analysis from the Perspective of Italian National Health Service по Bonfanti M, Fardella M, Morani M, Oliva S, Savarino EV, Giodice R, Saab JP, Castagnaro E, Tassone A, Restelli U

Полный текст

Role of Inhaled Methoxyflurane in the Management of Acute Trauma Pain по Fabbri A, Ruggiano G, Garcia Collado S, Ricard-Hibon A, Restelli U, Sbrana G, Marinangeli F, Farina A, Coffey F

Полный текст

Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey [Corrigendum] по Innocenti R, Rigacci L, Restelli U, Scappini B, Gianfaldoni G, Fanci R, Mannelli F, Scolari F, Croce D, Bonizzoni E, Perrone T, Bosi A

Полный текст

Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey по Innocenti R, Rigacci L, Restelli U, Scappini B, Gianfaldoni G, Fanci R, Mannelli F, Scolari F, Croce D, Bonizzoni E, Perrone T, Bosi A

Полный текст

Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district по Polilli E, Cento V, Restelli U, Ceccherini-Silberstein F, Aragri M, Di Maio VC, Sciacca A, Santoleri F, Fazii P, Costantini A, Perno CF, Parruti G

Полный текст